↓ Skip to main content

A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma

Overview of attention for article published in Tumor Biology, September 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
28 Mendeley
Title
A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma
Published in
Tumor Biology, September 2015
DOI 10.1007/s13277-015-4130-7
Pubmed ID
Authors

Chun-Lin Zhang, Kun-Peng Zhu, Guo-Qi Shen, Zhong-Sheng Zhu

Abstract

Long non-coding RNAs (lncRNAs) are emerging in molecular biology as crucial regulators of cancer. Although the aberrant expression of lncRNAs has been observed in osteosarcoma (OS), the molecular mechanisms underlying lncRNAs in doxorubicin resistance of OS still unknown. In the current study, we investigated a novel lncRNA, termed ODRUL (osteosarcoma doxorubicin-resistance related up-regulated lncRNA), and evaluated its role in the occurrence of doxorubicin resistance in OS. LncRNA microarray revealed that lncRNA ODRUL was the most up-regulated expressed in the doxorubicin-resistant OS cell line. Quantitative real-time PCR (qRT-PCR) confirmed that lncRNA ODRUL was higher in different doxorubicin-resistant OS cell lines and lower in different doxorubicin-sensitive OS cell lines. Moreover, we showed that lncRNA ODRUL was increased in specimens of OS patients with a poor chemoresponse and lung metastasis. We further demonstrated that lncRNA ODRUL inhibition could inhibit OS cell proliferation, migration, and partly reversed doxorubicin resistance in vitro. In addition, we found that the expression of classical drug resistance-related ATP-binding cassette, subfamily B, member 1 (ABCB1) gene was decreased after the lncRNA ODRUL knockdown. Thus, we concluded that lncRNA ODRUL may act as a pro-doxorubicin-resistant molecule through inducing the expression of the classical multidrug resistance-related ABCB1 gene in osteosarcoma cells .These findings may provide a novel target for reversing doxorubicin resistance in OS.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 4%
Unknown 27 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 25%
Student > Bachelor 5 18%
Researcher 3 11%
Student > Master 3 11%
Professor 2 7%
Other 4 14%
Unknown 4 14%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 32%
Medicine and Dentistry 6 21%
Agricultural and Biological Sciences 2 7%
Immunology and Microbiology 2 7%
Psychology 1 4%
Other 3 11%
Unknown 5 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2019.
All research outputs
#8,269,628
of 25,393,528 outputs
Outputs from Tumor Biology
#430
of 2,676 outputs
Outputs of similar age
#94,058
of 286,264 outputs
Outputs of similar age from Tumor Biology
#26
of 253 outputs
Altmetric has tracked 25,393,528 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 2,676 research outputs from this source. They receive a mean Attention Score of 2.5. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,264 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 253 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.